JP2005506369A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005506369A5 JP2005506369A5 JP2003537629A JP2003537629A JP2005506369A5 JP 2005506369 A5 JP2005506369 A5 JP 2005506369A5 JP 2003537629 A JP2003537629 A JP 2003537629A JP 2003537629 A JP2003537629 A JP 2003537629A JP 2005506369 A5 JP2005506369 A5 JP 2005506369A5
- Authority
- JP
- Japan
- Prior art keywords
- irbesartan
- pharmaceutical composition
- hydrochlorothiazide
- composition according
- diuretics
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002947 C09CA04 - Irbesartan Substances 0.000 claims 3
- YCPOHTHPUREGFM-UHFFFAOYSA-N irbesartan Chemical compound O=C1N(CC=2C=CC(=CC=2)C=2C(=CC=CC=2)C=2[N]N=NN=2)C(CCCC)=NC21CCCC2 YCPOHTHPUREGFM-UHFFFAOYSA-N 0.000 claims 3
- 229960002198 irbesartan Drugs 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- JZUFKLXOESDKRF-UHFFFAOYSA-N Chlorothiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NCNS2(=O)=O JZUFKLXOESDKRF-UHFFFAOYSA-N 0.000 claims 2
- 239000002934 diuretic Substances 0.000 claims 2
- 229940030606 diuretics Drugs 0.000 claims 2
- 229960002003 hydrochlorothiazide Drugs 0.000 claims 2
- 229940118365 Endothelin receptor antagonist Drugs 0.000 claims 1
- 206010064911 Pulmonary arterial hypertension Diseases 0.000 claims 1
- GXBMIBRIOWHPDT-UHFFFAOYSA-N Vasopressin Natural products N1C(=O)C(CC=2C=C(O)C=CC=2)NC(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C1CC1=CC=CC=C1 GXBMIBRIOWHPDT-UHFFFAOYSA-N 0.000 claims 1
- 102000002852 Vasopressins Human genes 0.000 claims 1
- 108010004977 Vasopressins Proteins 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 239000003146 anticoagulant agent Substances 0.000 claims 1
- 229940127219 anticoagulant drug Drugs 0.000 claims 1
- KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 claims 1
- GJPICJJJRGTNOD-UHFFFAOYSA-N bosentan Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCO)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 GJPICJJJRGTNOD-UHFFFAOYSA-N 0.000 claims 1
- 229960003065 bosentan Drugs 0.000 claims 1
- 229940082638 cardiac stimulant phosphodiesterase inhibitors Drugs 0.000 claims 1
- 239000002308 endothelin receptor antagonist Substances 0.000 claims 1
- 229960001123 epoprostenol Drugs 0.000 claims 1
- KAQKFAOMNZTLHT-VVUHWYTRSA-N epoprostenol Chemical compound O1C(=CCCCC(O)=O)C[C@@H]2[C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C[C@@H]21 KAQKFAOMNZTLHT-VVUHWYTRSA-N 0.000 claims 1
- 239000002571 phosphodiesterase inhibitor Substances 0.000 claims 1
- 208000002815 pulmonary hypertension Diseases 0.000 claims 1
- 239000002464 receptor antagonist Substances 0.000 claims 1
- 229940044551 receptor antagonist Drugs 0.000 claims 1
- 229940124549 vasodilator Drugs 0.000 claims 1
- 239000003071 vasodilator agent Substances 0.000 claims 1
- 229960003726 vasopressin Drugs 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0113936A FR2831446B1 (fr) | 2001-10-26 | 2001-10-26 | Utilisation de l'irbesartan pour la preparation de medicaments utiles pour la prevention ou le traitement de l'hypertension pulmonaire |
| PCT/FR2002/003439 WO2003035062A1 (fr) | 2001-10-26 | 2002-10-09 | Utilisation de l'irbesartan pour la preparation de medicaments utiles pour la prevention ou le traitement de l'hypertension pulmonaire |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005506369A JP2005506369A (ja) | 2005-03-03 |
| JP2005506369A5 true JP2005506369A5 (enExample) | 2006-01-05 |
| JP4542777B2 JP4542777B2 (ja) | 2010-09-15 |
Family
ID=8868812
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003537629A Expired - Fee Related JP4542777B2 (ja) | 2001-10-26 | 2002-10-09 | 肺高血圧症を予防または治療するのに用いられる医薬の製造のためのイルベサルタンの使用 |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US20040242567A1 (enExample) |
| EP (1) | EP1441723B1 (enExample) |
| JP (1) | JP4542777B2 (enExample) |
| CN (1) | CN100418526C (enExample) |
| AT (1) | ATE361071T1 (enExample) |
| AU (1) | AU2002350832B2 (enExample) |
| BR (1) | BR0213479A (enExample) |
| CA (1) | CA2461625C (enExample) |
| CY (1) | CY1106746T1 (enExample) |
| DE (1) | DE60219940T2 (enExample) |
| DK (1) | DK1441723T3 (enExample) |
| EA (1) | EA007952B1 (enExample) |
| ES (1) | ES2286304T3 (enExample) |
| FR (1) | FR2831446B1 (enExample) |
| HU (1) | HUP0401633A3 (enExample) |
| IL (2) | IL161116A0 (enExample) |
| IS (1) | IS2849B (enExample) |
| MX (1) | MXPA04003910A (enExample) |
| NO (1) | NO332313B1 (enExample) |
| NZ (1) | NZ532130A (enExample) |
| PL (1) | PL209263B1 (enExample) |
| PT (1) | PT1441723E (enExample) |
| WO (1) | WO2003035062A1 (enExample) |
| ZA (1) | ZA200402696B (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7811606B2 (en) | 2003-04-16 | 2010-10-12 | Dey, L.P. | Nasal pharmaceutical formulations and methods of using the same |
| US9808471B2 (en) | 2003-04-16 | 2017-11-07 | Mylan Specialty Lp | Nasal pharmaceutical formulations and methods of using the same |
| US8912174B2 (en) | 2003-04-16 | 2014-12-16 | Mylan Pharmaceuticals Inc. | Formulations and methods for treating rhinosinusitis |
| US20040265238A1 (en) * | 2003-06-27 | 2004-12-30 | Imtiaz Chaudry | Inhalable formulations for treating pulmonary hypertension and methods of using same |
| TR200301553A1 (tr) * | 2003-09-18 | 2005-10-21 | Nobel �La� Sanay�� Ve T�Caret A.�. | İrbesartan etken maddesi içeren yeni oral farmasötik formülasyonlar |
| JP4880591B2 (ja) | 2004-06-04 | 2012-02-22 | テバ ファーマシューティカル インダストリーズ リミティド | イルベサルタンを含む医薬組成物 |
| WO2006067601A1 (en) * | 2004-12-23 | 2006-06-29 | Ranbaxy Laboratories Limited | Oral pharmaceutical compositions of irbesartan and hydrochlorothiazide and processes for their preparation |
| CN100367959C (zh) * | 2006-08-29 | 2008-02-13 | 陈俊云 | 一种含有依贝沙坦的药物 |
| GB0617171D0 (en) * | 2006-08-31 | 2006-10-11 | Generics Uk Ltd | Novel compositions and methods |
| JP2024510446A (ja) * | 2021-03-23 | 2024-03-07 | ダイメリックス バイオサイエンス ピーティーワイ リミテッド | 炎症性疾患の処置 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5258510A (en) * | 1989-10-20 | 1993-11-02 | Otsuka Pharma Co Ltd | Benzoheterocyclic compounds |
| TW201738B (enExample) * | 1990-03-20 | 1993-03-11 | Sanofi Co | |
| US5270317A (en) * | 1990-03-20 | 1993-12-14 | Elf Sanofi | N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present |
| RU2086544C1 (ru) * | 1991-06-13 | 1997-08-10 | Хоффманн-Ля Рош АГ | Бензолсульфонамидные производные пиримидина или их соли, фармацевтическая композиция для лечения заболеваний, связанных с активностью эндотелина |
| US5292741A (en) * | 1992-08-18 | 1994-03-08 | Merck & Co., Inc. | Macrocycles incorporating quinazolinones |
| US20020068740A1 (en) | 1999-12-07 | 2002-06-06 | Mylari Banavara L. | Combination of aldose reductase inhibitors and antihypertensive agents for the treatment of diabetic complications |
-
2001
- 2001-10-26 FR FR0113936A patent/FR2831446B1/fr not_active Expired - Fee Related
-
2002
- 2002-10-09 WO PCT/FR2002/003439 patent/WO2003035062A1/fr not_active Ceased
- 2002-10-09 PL PL368737A patent/PL209263B1/pl unknown
- 2002-10-09 ES ES02785535T patent/ES2286304T3/es not_active Expired - Lifetime
- 2002-10-09 EA EA200400438A patent/EA007952B1/ru not_active IP Right Cessation
- 2002-10-09 US US10/492,804 patent/US20040242567A1/en not_active Abandoned
- 2002-10-09 IL IL16111602A patent/IL161116A0/xx unknown
- 2002-10-09 AT AT02785535T patent/ATE361071T1/de active
- 2002-10-09 CA CA2461625A patent/CA2461625C/en not_active Expired - Fee Related
- 2002-10-09 PT PT02785535T patent/PT1441723E/pt unknown
- 2002-10-09 HU HU0401633A patent/HUP0401633A3/hu unknown
- 2002-10-09 JP JP2003537629A patent/JP4542777B2/ja not_active Expired - Fee Related
- 2002-10-09 MX MXPA04003910A patent/MXPA04003910A/es active IP Right Grant
- 2002-10-09 CN CNB028213041A patent/CN100418526C/zh not_active Expired - Fee Related
- 2002-10-09 DE DE60219940T patent/DE60219940T2/de not_active Expired - Lifetime
- 2002-10-09 AU AU2002350832A patent/AU2002350832B2/en not_active Ceased
- 2002-10-09 DK DK02785535T patent/DK1441723T3/da active
- 2002-10-09 EP EP02785535A patent/EP1441723B1/fr not_active Expired - Lifetime
- 2002-10-09 BR BR0213479-9A patent/BR0213479A/pt not_active Application Discontinuation
- 2002-10-09 NZ NZ532130A patent/NZ532130A/en not_active IP Right Cessation
-
2004
- 2004-03-25 IL IL161116A patent/IL161116A/en not_active IP Right Cessation
- 2004-03-29 IS IS7200A patent/IS2849B/is unknown
- 2004-04-06 ZA ZA2004/02696A patent/ZA200402696B/en unknown
- 2004-04-23 NO NO20041732A patent/NO332313B1/no not_active IP Right Cessation
-
2007
- 2007-07-19 CY CY20071100964T patent/CY1106746T1/el unknown
-
2009
- 2009-06-03 US US12/477,562 patent/US8088827B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE461932T1 (de) | Pyrazoloä4,3-eü-1,2,4-triazoloä1,5-cüpyrimidine als antagonisten des adenosin-a2a-rezeptors | |
| JP2005506369A5 (enExample) | ||
| WO2004096798A3 (fr) | Derives de 2-acylamino-4-phenylthiazole, leur preparation et leur application en therapeutique | |
| BR0313629B1 (pt) | composiÇço detergente bifÁsica lÍquida aquosa de limpeza pessoal. | |
| BR9911621A (pt) | Bifenil sulfonamidas como antagonista duplos de receptor de angiotensina endotelina | |
| DE122012000018I1 (de) | Benzimidazolderivate und ihre verwendung als antagonisten des a II rezeptors. | |
| EP2001485A4 (en) | DIAZEPANOREXIN Receptor Antagonists | |
| JP2003520232A5 (enExample) | ||
| WO2002081430A3 (en) | Novel benzylideneamino guanidines and their uses as ligands to the melanocortin receptors | |
| JP2005526147A5 (enExample) | ||
| MX2009005174A (es) | Derivados de 5-sulfanilmetil-[1,2,4]triazol[1,5-a]pirimidin-7-ol como antagonistas de cxcr2. | |
| EP1195166A3 (en) | Use of a vasopressin antagonist such as conivaptan in the manufacture of a medicament for treating pulmonary hypertension | |
| JP2007191765A5 (enExample) | ||
| NO20075662L (no) | Roflumilast for behandlingen av pulmonal hypertensjon | |
| JP2007510403A5 (enExample) | ||
| DE60318547D1 (de) | Agonisten des corticotropin-freisetzenden faktor rezeptors 2 | |
| WO2007075964A3 (en) | Thrombin receptor antagonists as prophylaxis to complications from cardiopulmonary surgery | |
| WO2005075450A3 (en) | Spiro-benzodioxoles and their use as cb1 antagonists | |
| WO2001068568A3 (en) | Il-8 receptor antagonists | |
| JP2004534810A5 (enExample) | ||
| WO2007070523A3 (en) | Personal care compositions comprising ppar. gamma. antagonists | |
| WO2004039775A3 (en) | Il-8 receptor antagonists | |
| ECSP066306A (es) | Modificaciones estables de maleato ácido de tegaserod | |
| IS7705A (is) | 4-(3,5-Dísýanófenoxý) pýrasól afleiður til notkunar sem bakritunarstillar við meðhöndlun á m.a. eyðniveirunni | |
| DE502005008620D1 (de) | NEUE KRISTALLINE FORM VON 8-CYAN-1-CYCLOPROPYL-7-(1S,6S-2,8-DIAZABICYCLOi4.3.0 NONAN-8-YL)-6-FLUOR-1,4-DIHYDRO-4-OXO-3-CHINOLINCARBONSÄURE |